150 related articles for article (PubMed ID: 225025)
1. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG
Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025
[TBL] [Abstract][Full Text] [Related]
2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
3. Incidence of localized feline leukemia virus infection in cats.
Hayes KA; Rojko JL; Mathes LE
Am J Vet Res; 1992 Apr; 53(4):604-7. PubMed ID: 1316726
[TBL] [Abstract][Full Text] [Related]
4. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
5. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
6. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum.
Rice JB; Olsen RG
J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553
[TBL] [Abstract][Full Text] [Related]
7. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
Hoover EA; Olsen RG; Mathes LE; Schaller JP
Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a feline leukemia virus vaccine in a controlled natural transmission study.
Lafrado LJ
J Am Vet Med Assoc; 1994 Mar; 204(6):914-7. PubMed ID: 8188511
[TBL] [Abstract][Full Text] [Related]
10. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection.
Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW
J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857
[TBL] [Abstract][Full Text] [Related]
11. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
12. Effect of continuous oral diethylcarbamazine treatment on lymphocyte counts of feline leukemia virus-infected cats.
Kitchen LW; Mather FJ; Cotter SM
J Clin Lab Immunol; 1988 Dec; 27(4):179-81. PubMed ID: 2855080
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
Hines DL; Cutting JA; Dietrich DL; Walsh JA
J Am Vet Med Assoc; 1991 Nov; 199(10):1428-30. PubMed ID: 1666097
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
[TBL] [Abstract][Full Text] [Related]
15. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
[TBL] [Abstract][Full Text] [Related]
16. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
[TBL] [Abstract][Full Text] [Related]
17. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats.
Tandon R; Cattori V; Pepin AC; Riond B; Meli ML; McDonald M; Doherr MG; Lutz H; Hofmann-Lehmann R
Virus Res; 2008 Jul; 135(1):136-43. PubMed ID: 18407367
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
19. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
Snyder HW; Singhal MC; Hardy WD; Jones FR
J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
[TBL] [Abstract][Full Text] [Related]
20. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets.
Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
